AU2003246592A1 - Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases - Google Patents
Tumour marker and the use thereof for the diagnosis and treatment of tumour diseasesInfo
- Publication number
- AU2003246592A1 AU2003246592A1 AU2003246592A AU2003246592A AU2003246592A1 AU 2003246592 A1 AU2003246592 A1 AU 2003246592A1 AU 2003246592 A AU2003246592 A AU 2003246592A AU 2003246592 A AU2003246592 A AU 2003246592A AU 2003246592 A1 AU2003246592 A1 AU 2003246592A1
- Authority
- AU
- Australia
- Prior art keywords
- tumour
- diagnosis
- treatment
- diseases
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/24—Extraction; Separation; Purification by electrochemical means
- C07K1/26—Electrophoresis
- C07K1/28—Isoelectric focusing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10229386 | 2002-06-26 | ||
DE10229386.4 | 2002-06-26 | ||
PCT/EP2003/006748 WO2004003564A2 (en) | 2002-06-26 | 2003-06-26 | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003246592A1 true AU2003246592A1 (en) | 2004-01-19 |
Family
ID=29796039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003246592A Abandoned AU2003246592A1 (en) | 2002-06-26 | 2003-06-26 | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003246592A1 (en) |
WO (1) | WO2004003564A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ME01881B (en) | 2004-01-22 | 2014-12-20 | Univ Miami | Topical co-enzyme q10 formulations and methods of use |
ES2755840T3 (en) | 2007-03-22 | 2020-04-23 | Berg Llc | Topical formulations that have increased bioavailability |
KR20100136997A (en) | 2008-04-11 | 2010-12-29 | 싸이토테크 랩스, 엘엘씨 | Methods and use of inducing apoptosis in cancer cells |
EP2334791B1 (en) * | 2008-08-18 | 2016-07-13 | Medicinal Bioconvergence Research Center | Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
CA2761717A1 (en) | 2009-05-11 | 2010-11-18 | Berg Biosystems, Llc | Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
CN102892412B (en) | 2010-03-12 | 2015-09-30 | 博格制药有限责任公司 | The iv formulation of coenzyme Q10 (CoQ10) and using method thereof |
AU2012240222B2 (en) | 2011-04-04 | 2017-04-27 | Berg Llc | Methods of treating central nervous system tumors |
US10973763B2 (en) | 2011-06-17 | 2021-04-13 | Berg Llc | Inhalable pharmaceutical compositions |
MX2015014097A (en) | 2013-04-08 | 2016-06-07 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies. |
IL276423B2 (en) | 2013-09-04 | 2024-05-01 | Berg Llc | Compositions comprising coenzyme q10 for use in the treatment of cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
-
2003
- 2003-06-26 WO PCT/EP2003/006748 patent/WO2004003564A2/en not_active Application Discontinuation
- 2003-06-26 AU AU2003246592A patent/AU2003246592A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004003564A2 (en) | 2004-01-08 |
WO2004003564A3 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004030615A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004016225A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004045516A9 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004060270A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1571968A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
WO2003057160A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1572091A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1553912A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
AU2002226690A1 (en) | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases | |
WO2005003154A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003246592A1 (en) | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases | |
AU2003209150A1 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
AU2003237792A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
AU2003245927A1 (en) | Target genes for the diagnosis and treatment of cancer | |
AU2002364501A1 (en) | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer | |
AU2003303217A1 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
AU2003230849A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2003250912A1 (en) | Agents and methods for diagnosis and therapy of cancer and cancer risk assessment | |
AU2003245858A1 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
WO2005052191A8 (en) | Compositions and methods for the diagnosis and treatment of tumor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |